Win-Partners Co

Win-Partners Co Interest Expense

The Interest Expense of Win-Partners Co (3183.T) as of Oct 28, 2026 is 47.77 M JPY. In the previous year, Interest Expense was 75.13 M JPY — a change of -36.42% (lower).

Interest Expense

47.77 MJPY

YoY

-36.42%

Last updated:

Interest Expense of Win-Partners Co is 2025 47.77 M JPY. Interest Expense of Win-Partners Co was 2024 75.13 M JPY. It decreases by -36.42% lower compared to the previous year.

The Win-Partners Co Interest Expense history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Expense
Date
Interest Expense
Jan 1, 2018
40.26 M JPY
Jan 1, 2019
-43,000.00 JPY
Jan 1, 2020
84.66 M JPY
Jan 1, 2021
2.25 M JPY
Jan 1, 2022
1.35 M JPY
Jan 1, 2023
29.56 M JPY
Jan 1, 2024
75.13 M JPY
Jan 1, 2025
47.77 M JPY
The Win-Partners Co Interest Expense history
YEARInterest ExpenseYoY
47.77 MJPY-36.42%
75.13 MJPY+154.13%
29.56 MJPY+2,083.46%
1.35 MJPY-39.77%
2.25 MJPY-97.34%
84.66 MJPY-196,990.70%
-43,000.00JPY-100.11%
40.26 MJPY+4,178.11%
941,000.00JPY-99.54%
206.54 MJPY+2,558.84%
7.77 MJPY+10.97%
7.00 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Win-Partners Co Stock analysis

What does Win-Partners Co do? WIN-Partners Co., Ltd. generates revenue through the management of its group of companies specializing in medical device sales. The company offers catheters for ischemic heart disease, pacemakers for cardiac rhythm management, artificial blood vessels for cardiovascular surgery, and embolization coils for peripheral vascular disease and brain surgery. Additionally, it provides large-scale medical equipment including computed tomography (CT) systems for radiology departments and operating rooms. Its primary customers are healthcare institutions requiring advanced medical technology solutions. The company's product portfolio targets specific medical specialties, with catheters, pacemakers, and artificial blood vessels serving cardiovascular applications. Embolization coils address vascular and neurological procedures, while CT equipment supports diagnostic imaging needs across various hospital departments. These offerings are distributed through the company's managed group of medical device sales entities. WIN-Partners focuses on high-value medical devices that require specialized sales channels and technical support. Its business model centers on managing a network of companies that handle the distribution and sales of these medical technologies to hospitals and clinics. The firm's revenue streams are derived from the sale of these specialized medical devices and equipment to healthcare providers in Japan and potentially international markets. Win-Partners Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Win-Partners Co stock

Interest Expense of Win-Partners Co is 47.77 M JPY in 2025.

Interest Expense of Win-Partners Co changed from 75.13 M JPY to 47.77 M JPY, representing a -36.42% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Expense Win-Partners Co since 2006 – with annual values, charts, and detailed analysis.

Interest expense represents the cost of borrowing. Higher interest expenses can indicate a highly leveraged company.

Interest Expense's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Interest Expense's Win-Partners Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Win-Partners Co

All Key Metrics — Win-Partners Co